New Dems Urge House Leadership to Move Bipartisan Drug Pricing Bills
WASHINGTON – Members of the New Democrat Coalition’s Healthcare Task Force asked the House leadership on Wednesday to hold a floor vote on drug pricing bills with bipartisan support as early as next week.
The request was made in a letter sent to House Speaker Nancy Pelosi, Majority Leader Steny Hoyer, Majority Whip Jim Clyburn, and Assistant Leader Ben Ray Luján.
In it, Representatives Angie Craig, of Minnesota, Kurt Schrader, of Oregon, Kim Schrier, of Washington, and Greg Stanton, of Arizona, say while they support efforts to stabilize and expand on the Affordable Care Act, their constituents are demanding action be taken soon to curb the rising costs of prescription drugs.
The task force members ask the House leaders to consider bringing the bipartisan drug pricing bills included in H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act, to the floor in a standalone package for a vote next week when other healthcare measures are expected to be considered.
“Each of the drug pricing bills in H.R. 987 had bipartisan support when introduced, as well as through the Committee process,” the representatives say.
“While we were optimistic our Republican colleagues would support commonsense fixes to strengthen the ACA, this comprehensive package was passed out of the House with only Democratic support,” they continue. “Consequently, our colleagues in the Senate have yet to vote on these noncontroversial drug pricing measures and send them to the President for enactment.”
The representatives note that at least three bills in the package would have an immediate moderating effect on prescription drug prices.
These include H.R. 965, the CREATES Act, introduced by Representative David Cicilline, of Rhode Island; H.R. 938, the BLOCKING Act, introduced by Representative Kurt Schrader, of Oregon; and H.R. 1499, the Protecting Consumer Access to Generic Drugs Act, introduced by Representative Bobby Rush, of Illinois.
The New Democrat Coalition members closed by reminding the House leaders and their colleagues across the aisle that “the rising cost of prescription drugs remains of paramount concern to all members, irrespective of political affiliation.
“There are families in every single congressional district struggling to pay for their prescription drugs. As such, this challenge calls for a unified approach. Respectfully, we urge leadership to bring these bipartisan measures to the floor and, in doing so, reiterate our commitment to tackling the rising cost of prescription drugs in a bipartisan manner before the August recess,” the members say.
In The News
Over the last two weeks, China and the U.S. have made dueling comments about whether Taiwan should be admitted to this year's World Health Assembly, the meeting where priorities and policies of the World Health Organization are set, which will be held later this month. U.S.... Read More
WASHINGTON (AP) — U.S. restaurants and stores are rapidly raising pay in an urgent effort to attract more applicants and keep up with a flood of customers as the pandemic eases. McDonald's, Sheetz and Chipotle are just some of the latest companies to follow Amazon, Walmart ... Read More
The Centers for Disease Control and Prevention issued new guidance that people who are fully vaccinated against COVID-19 can safely resume life without any restrictions. "The science is clear: if you are fully vaccinated, you are protected, and you can start doing the things that you... Read More
WASHINGTON -- Infectious disease experts urged Congress Wednesday to move quickly to vaccinate Americans before the COVID-19 virus mutates to become more dangerous. Without fast action to create herd immunity, emerging virus strains could make current vaccines less effective, experts told the House Science, Space and... Read More
The White House is stepping up its efforts to encourage the parents of adolescents age 12-15 to get their kids vaccinated against COVID-19.Earlier this week, the Food and Drug Administration expanded the emergency use authorization for the Pfizer BioN-Tech vaccine to include individuals ages 12-15. On... Read More
Researchers from Emory University are working on a National Institutes of Health-supported project to develop a sensor capable of detecting COVID-19 in the air, called Rolosense. “It’s tricky to anticipate what the real-world implementation will be of this technology, but we anticipate this will fill a... Read More